Wyeth

Merck to cut 1,200 sales reps

admin — Tue, 06 May 2008 06:59:58 -0400

The axeman cometh to Merck's sales force. The drugmaker plans to lop off about 15 percent in the sales ranks, or 1,200 jobs. The fact that it's not alone in trimming back on reps--Wyeth just Read more...

Enbrel gets black-box infection warning

admin — Fri, 02 May 2008 06:59:56 -0400

Enbrel's new black box is now official. Wyeth and Amgen have put the final touches on a Read more...

Wyeth to slash another 1,200 jobs

admin — Tue, 29 Apr 2008 06:59:58 -0400

And the ax is falling again. Wyeth notified employees last Friday than another 1,200 jobs will be slashed from the payroll. That's on top of the Read more...

Lundbeck poaches CEO from Wyeth ranks

admin — Tue, 29 Apr 2008 06:59:55 -0400

Wanted: CEO who can find a new "cash cow" to push a Danish drugmaker past impending patent expirations. Found: Ulf Wiinberg, lately of Wyeth, to take over Lundbeck. Soon to be ex-president Read more...

Wyeth discounts Pristiq for big sales push

admin — Wed, 23 Apr 2008 06:59:54 -0400

Think the latest-and-greatest drug would naturally be the most expensive? Think again. Now that its Pristiq antidepressant is Read more...

SPOTLIGHT: Wyeth sales boosted by Enbrel

admin — Tue, 22 Apr 2008 06:59:52 -0400

Despite major erosion in sales of its heartburn blockbuster Protonix, Wyeth managed to beat Wall Street's expectations for first-quarter earnings, posting a $1.2 billion profit on a 6 percent Read more...

Strategy execs advise Big Pharma

admin — Mon, 14 Apr 2008 06:59:56 -0400

How might drugmakers navigate the rocky waters of generic competition, cautious regulators, safety scandals, globalization, and so on? Seek help with the itinerary from an expert, perhaps. At least Read more...

1,200 Wyeth reps out of work

admin — Fri, 28 Mar 2008 07:59:58 -0400

Don't tell these 1,200 Wyeth sales reps to have a nice weekend. They got pink slips on Wednesday, their jobs eliminated in the drugmaker's Read more...

CFOs are pharma's new power players

admin — Thu, 27 Mar 2008 07:59:58 -0400

Who's pharma's power forward these days? The CFO. Or so concludes Ernst & Young after slicing and dicing two global surveys. As companies shift focus from driving sales growth to managing Read more...

BMS chief nabs $10 million raise

admin — Tue, 25 Mar 2008 07:59:58 -0400

Why is Jim Cornelius (photo) smiling? His big promotion to permanent CEO of Bristol-Myers Squibb Read more...